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ORIGINAL ARTICLE
Alcohol Consumption and Cardiovascular Disease
A Mendelian Randomization Study
Susanna C. Larsson, PhD; Stephen Burgess, PhD; Amy M. Mason, PhD; Karl Michaëlsson, PhD, MD
BACKGROUND: The causal role of alcohol consumption for cardiovascular disease remains unclear. We used Mendelian 
randomization (MR) to predict the effect of alcohol consumption on 8 cardiovascular diseases.
METHODS: Up to 94 single-nucleotide polymorphisms were used as instrumental variables for alcohol consumption. Genetic 
association estimates for cardiovascular diseases were obtained from large-scale consortia and UK Biobank. Analyses were 
conducted using the inverse variance–weighted, weighted median, MR-PRESSO, MR-Egger, and multivariable MR methods.
RESULTS: Genetically predicted alcohol consumption was consistently associated with stroke and peripheral artery disease 
across the different analyses. The odds ratios (ORs) per 1-SD increase of log-transformed alcoholic drinks per week 
were 1.27 ([95% CI, 1.12–1.45] P=2.87×10−4) for stroke and 3.05 ([95% CI, 1.92–4.85] P=2.30×10−6) for peripheral 
artery disease in the inverse variance–weighted analysis. There was some evidence for positive associations of genetically 
predicted alcohol consumption with coronary artery disease (OR, 1.16 [95% CI, 1.00–1.36]; P=0.052), atrial fibrillation (OR, 
1.17 [95% CI, 1.00–1.37]; P=0.050), and abdominal aortic aneurysm (OR, 2.60 [95% CI, 1.15–5.89]; P=0.022) in the 
inverse variance–weighted analysis. These associations were somewhat attenuated in multivariable MR analysis adjusted 
for smoking initiation. There was no evidence of associations of genetically predicted alcohol consumption with heart failure 
(OR, 1.00 [95% CI, 0.68–1.47]; P=0.996), venous thromboembolism (OR, 1.04 [95% CI, 0.77–1.39]; P=0.810), and aortic 
valve stenosis (OR, 1.03 [95% CI, 0.56–1.90]; P=0.926).
CONCLUSIONS: This study provides evidence of a causal relationship between higher alcohol consumption and increased risk 
of stroke and peripheral artery disease. The causal role of alcohol consumption for other cardiovascular diseases requires 
further research.
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Heavy alcohol consumption is an important cause of death and disability,1 but the association between moderate drinking and cardiovascular disease (CVD) 
is complex. On a population level, given its widespread 
nature, it is important to disentangle any risks or bene-
fits of alcohol consumption. Observational studies have 
generally shown that alcohol consumption is positively 
associated with risk of atrial fibrillation,2 heart failure,3 
and hemorrhagic stroke,4 whereas moderate drinking 
is associated with lower risk of coronary heart disease 
and ischemic stroke.3–6 Data from observational stud-
ies on alcohol consumption in relation to other CVDs, 
including venous thromboembolism,7,8 peripheral artery 
disease,9 aortic valve stenosis,10 and abdominal aortic 
aneurysm,9,11,12 are limited or inconsistent. Observational 
studies are unable to fully account for confounding 
and reverse causation bias, and, therefore, causality in 
the associations of alcohol consumption with differ-
ent CVDs remains uncertain. Furthermore, self-reported 
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measurement error in the assessment of alcohol con-
sumption, which may result in attenuated categorical risk 
estimates.
Mendelian randomization (MR) is an epidemiological 
technique that utilizes genetic variants that are reliably 
associated with a potentially modifiable risk factor to 
determine its causal role for disease risk.13 MR studies 
are less vulnerable to bias from confounding, reverse 
causation, and measurement error compared with con-
ventional observational studies. In a previous MR study 
in a population of European ancestry, increased alco-
hol intake instrumented by a single-nucleotide poly-
morphism (SNP; rs1229984) in the ADH1B gene was 
associated with higher risk of coronary heart disease and 
ischemic stroke,14 which contradicts observational find-
ings.3–6 Results from a recent MR study conducted in a 
Chinese population showed that increased alcohol con-
sumption instrumented by 2 alcohol-associated SNPs 
(rs1229984 in ADH1B and rs671 in ALDH2) was asso-
ciated with higher risk of ischemic stroke and intracere-
bral hemorrhage but was not associated with myocardial 
infarction.15 To our knowledge, the association between 
alcohol consumption and CVD other than stroke and 
coronary heart disease has not been studied using MR.
A recent genome-wide association meta-analysis 
identified multiple SNPs associated with alcohol con-
sumption.16 By using those SNPs as instrumental vari-
ables, we here perform an MR study to investigate the 
potential causal relationship between alcohol con-
sumption and 8 CVDs, including stroke, coronary artery 
disease, atrial fibrillation, heart failure, venous thrombo-
embolism, peripheral artery disease, aortic valve stenosis, 
and abdominal aortic aneurysm. In secondary analyses, 
we explored the associations of genetically predicted 
alcohol consumption with possible mediators (blood 
pressure and serum lipids) and confounders (smoking 
and education) of the alcohol-CVD associations.
METHODS
The methods used in this MR study are described in the 
Data Supplement. In brief, summary statistics data for alcohol 
consumption and the outcomes were obtained from meta-anal-
yses of genome-wide association studies and UK Biobank. All 
studies included in the genome-wide association studies were 
approved by an institutional review committee, and participants 
gave informed consent. This MR study was approved by the 
Swedish Ethical Review Authority. The data that support the 
findings of this study are available from the corresponding 
author upon reasonable request. Figure 1 provides an overview 
of this study, including the primary and secondary outcomes 
studied, the data sources used, and the principles and assump-
tions of the MR design.
RESULTS
Associations With Potential Mediators and 
Confounders
Alcohol consumption instrumented by the full set of 
SNPs (n=94) was positively associated with systolic 
and diastolic blood pressure and high-density lipoprotein 
cholesterol levels, inversely associated with triglyceride 
levels, but not associated with low-density lipoprotein 
cholesterol levels (Figure 2; Table VIII in the Data Sup-
plement). There was strong evidence of association of 
the overall genetic instrument for alcohol consumption 
with smoking initiation (odds ratio [OR], 1.24 [95% CI, 
1.15–1.33]; P=9.5×10−9) and weak evidence for educa-
tion (β=−0.09 years of schooling completed [95% CI, 
−0.17 to 0.00]; P=0.05).
Alcohol consumption instrumented by rs1229984 in 
ADH1B was positively associated with systolic and dia-
stolic blood pressure and low-density lipoprotein cho-
lesterol levels but was not associated with high-density 
lipoprotein cholesterol or triglyceride levels (Table IX 
in the Data Supplement). Genetically predicted alco-
hol consumption based on the ADH1B variant was not 
associated with smoking initiation (OR, 0.97 [95% CI, 
0.89–1.07]; P=0.57) but was inversely associated with 
education (β=−0.15 years of schooling completed [95% 
CI, −0.23 to −0.08]; P=5.4×10−5).
Associations With CVD
Alcohol consumption instrumented by the full set of 
SNPs was consistently associated with stroke and 
peripheral artery disease across different analyses 
(Figure 3; Table X in the Data Supplement). The ORs 
per 1-SD increase in log-transformed drinks per week 
were 1.27 ([95% CI, 1.12–1.45] P=2.87×10−4) for 
stroke and 3.05 ([95% CI, 1.92–4.85] P=2.30×10−6) 
for peripheral artery disease in the univariable inverse 
variance–weighted analysis. There was some evidence 
for positive associations of genetically predicted alco-
hol consumption with coronary artery disease (OR, 1.16 
[95% CI, 1.00–1.36]; P=0.052), atrial fibrillation (OR, 
1.17 [95% CI, 1.00–1.37]; P=0.050), and abdomi-
nal aortic aneurysm (OR, 2.60 [95% CI, 1.15–5.89]; 
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P=0.022) in the univariable inverse variance–weighted 
analysis (Figure 3; Table X in the Data Supplement). 
These associations were somewhat attenuated in mul-
tivariable MR analysis adjusting for smoking initiation 
(Figure 3; Table X in the Data Supplement). There was 
no evidence of association of genetically predicted alco-
hol consumption with heart failure (OR, 1.00 [95% CI, 
0.68–1.47]; P=0.996), venous thromboembolism (OR, 
1.04 [95% CI, 0.77–1.39]; P=0.810), and aortic valve 
stenosis (OR, 1.03 [95% CI, 0.56–1.90]; P=0.926) 
in the inverse variance–weighted analysis (Figure 3), 
but suggestive positive associations with aortic valve 
stenosis were observed in the weighted median and 
MR-Egger analyses (Table X in the Data Supplement). 
Indication of directional pleiotropy was only detected in 
the analysis of aortic valve stenosis (Table X in the Data 
Supplement). The associations between genetically 
predicted alcohol consumption and stroke and coro-
nary artery disease were similar when using data from 
the consortia (MEGASTROKE and Coronary Artery 
Disease Genome-Wide Replication and Meta-Analysis 
Plus the Coronary Artery Disease Genetics Consortium 
[CARDIoGRAMplusC4D]) and UK Biobank (Figure I in 
the Data Supplement). Restricting the analyses to never 
smokers in UK Biobank (Table XI in the Data Supple-
ment) yielded ORs that were similar to the smoking-
adjusted estimates, except for the association with 
coronary artery disease, which became stronger (OR, 
1.39 [95% CI, 0.98–1.96]; P=0.064).
The associations of alcohol consumption instru-
mented by all SNPs with stroke types in the MEGAS-
TROKE Consortium, UK Biobank, and International 
Stroke Genetics Consortium are presented in Figure 4. 
The OR for ischemic stroke combining the results from 
MEGASTROKE and UK Biobank was 1.26 ([95% CI, 
1.09–1.46] P=0.002). The corresponding OR for intra-
cerebral hemorrhage, combining the results from the 
International Stroke Genetics Consortium and UK Bio-
bank, was 3.53 ([95% CI, 1.70–7.32] P=0.001). Results 
for stroke and atrial fibrillation based on data from the 
Figure 1. Summary of the data sources for this study and the assumptions for the Mendelian randomization design.
Broken lines represent potential pleiotropic or direct causal effects between variables that would violate the Mendelian randomization 
assumptions. AFGen indicates Atrial Fibrillation Consortium; CAD, coronary artery disease; CARDIoGRAMplusC4D, Coronary Artery Disease 
Genome-Wide Replication and Meta-Analysis Plus the Coronary Artery Disease Genetics Consortium; GSCAN, GWAS and Sequencing 
Consortium of Alcohol and Nicotine Use; GWAS, genome-wide association study; ISGC, International Stroke Genetics Consortium; SNP, 
single-nucleotide polymorphism; SSGAC, Science Genetic Association Consortium; and UKBB, UK Biobank. *Reported are the outcome and 
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MEGASTROKE Consortium and Atrial Fibrillation Con-
sortium, respectively, were similar when restricting the 
study samples to European-descent individuals (Table 
XII in the Data Supplement).
Alcohol consumption instrumented by rs1229984 
in ADH1B was strongly or suggestively associated 
with higher odds of any stroke, coronary artery disease, 
peripheral artery disease, aortic valve stenosis, and 
abdominal aortic aneurysm (all P<0.05; Table XIII in the 
Data Supplement). There was suggestive evidence of a 
positive association of alcohol consumption instrumented 
by rs1229984 with ischemic stroke (OR, 1.31 [95% CI, 
Figure 3. Associations of alcohol consumption instrumented by the full set of single-nucleotide polymorphisms with CVD.
Odds ratios (ORs) are per SD increase of log-transformed alcoholic drinks per week, and results are based on the random-effects inverse 
variance–weighted (IVW) method and multivariable Mendelian randomization (MVMR) analysis adjusted for smoking initiation.
Figure 2. Associations of alcohol consumption instrumented by the full set of single-nucleotide polymorphisms with blood 
pressure and lipids.
The effect estimates are per SD increase of log-transformed alcoholic drinks per week, and results are based on the random-effects inverse 
variance–weighted method. DBP indicates diastolic blood pressure; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density 
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1.05–1.65]; P=0.018) and intracerebral hemorrhage 
(OR, 11.5 [95% CI, 1.31–101.46]; P=0.027). Results 
for the associations of the overall genetic instrument for 
alcohol consumption but with exclusion of rs1229984 
with CVD were similar (Table XIV in the Data Supple-
ment) to those based on the full set of SNPs.
DISCUSSION
Principal Findings
This MR study provides evidence that higher alcohol con-
sumption may be causally associated with increased risk 
of stroke and peripheral artery disease. There was also 
suggestive evidence for positive associations of geneti-
cally predicted alcohol consumption with coronary artery 
disease, atrial fibrillation, and abdominal aortic aneurysm, 
but the associations were attenuated after adjustment 
for smoking. Alcohol consumption instrumented by the 
full set of variants was additionally associated with higher 
blood pressure and high-density lipoprotein cholesterol 
levels and with lower triglyceride levels.
Comparison With Other Studies
Our findings for alcohol consumption, based on the 
ADH1B gene variant, in relation to stroke and coronary 
artery disease largely confirm the results from 2 earlier 
MR studies that utilized 1 or 2 SNPs as instrumental vari-
ables for alcohol consumption.14,15 An MR analysis of 261 
991 European-descent individuals, including 20 259 
coronary heart disease cases, found that each additional 
alcohol-decreasing allele of rs1229984 in the ADH1B 
gene was associated with a 10% lower odds of coronary 
heart disease.14 In the larger dataset (with 3× as many 
cases of coronary artery disease) used in the present 
MR analysis, we also observed that alcohol consump-
tion instrumented by rs1229984 was associated with 
coronary artery disease. In a cohort study of 161 490 
Chinese adults (China Kadoorie Biobank) genotyped for 
2 alcohol-associated SNPs (rs1229984 in ADH1B and 
rs671 in ALDH2), genetically predicted higher alcohol 
consumption was not associated with myocardial infarc-
tion but was associated with higher risk of stroke, par-
ticularly intracerebral hemorrhage.15 The present study 
confirms that those findings for stroke are also valid for 
individuals of European ancestry and that the association 
is stronger for intracerebral hemorrhage than ischemic 
stroke. The frequency of the alcohol-decreasing allele of 
rs1229984 is considerably higher in East Asians (overall 
frequency of 0.69 in China Kadoorie Biobank)15 than in 
individuals of European ancestry (0.026 in UK Biobank). 
The alcohol-decreasing allele of rs671 in the ALDH2 
gene is not found in European populations. We are not 
Figure 4. Associations of alcohol consumption instrumented by the full set of single-nucleotide polymorphisms with stroke 
types in the MEGASTROKE Consortium, UK Biobank, and International Stroke Genetics Consortium (ISGC).
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aware of any previous MR analysis of alcohol consump-
tion in relation to risk of atrial fibrillation, heart failure, 
venous thromboembolism, peripheral artery disease, aor-
tic valve stenosis, or abdominal aortic aneurysm.
The reason why rs1229984 in ADH1B was strongly 
associated with coronary artery disease, whereas only a 
suggestive association was observed between the overall 
genetic instrument for alcohol consumption and coronary 
artery disease, is unclear. However, the alcohol-increas-
ing allele of rs1229984 was inversely associated with 
education, which could potentially explain the associa-
tions through horizontal pleiotropy. Rs1229984 was also 
associated with low-density lipoprotein cholesterol, and 
both this variant and the overall genetic instrument for 
alcohol consumption were associated with blood pres-
sure. However, these associations may represent vertical 
(mediated) pleiotropy.
Possible Mechanisms
A possible mechanism whereby alcohol consumption 
may increase the risk of CVD is through blood pres-
sure. A meta-analysis of randomized trials showed that 
a reduction in alcohol intake decreased blood pressure 
in a dose-response manner in individuals who drank >2 
alcoholic drinks per day.17 In addition, genetically pre-
dicted alcohol consumption was positively associated 
with systolic blood pressure in previous MR studies,14,15 
and results were replicated by our study with both the 
overall genetic instrument for alcohol consumption and 
the ADH1B gene variant.
High-impact binge alcohol drinking is associated with 
increased odds of clinically high total serum cholesterol 
and triglyceride levels.18 In contrast, short-term interven-
tional studies have shown that moderate alcohol drink-
ing leads to favorable changes in several cardiovascular 
biomarkers, including higher levels of high-density lipo-
protein cholesterol and adiponectin and lower fibrinogen 
levels.19 We confirmed a positive association between 
genetically predicted alcohol intake and higher levels 
of high-density lipoprotein cholesterol. We additionally 
found that genetically higher alcohol consumption was 
associated with lower triglyceride levels. A causal posi-
tive association between triglyceride levels and risk of 
coronary artery disease20 but not ischemic stroke21 has 
been shown in MR studies.
Strengths and Limitations
Strengths of this study include the use of data from 
large studies of alcohol consumption and the out-
comes, the MR study design, and the use of mul-
tiple SNPs as instrumental variables for alcohol 
consumption. The MR approach reduces bias due to 
reverse causality and confounding. Reverse causality 
is minimized in MR studies because disease cannot 
modify genotype, which is fixed at conception. With 
regard to confounding factors, self-reported alcohol 
consumption is associated with higher educational 
attainment.6,22 In contrast, there is no genetic cor-
relation between education and alcohol consump-
tion (rg=0.01),
16 and we found no association of the 
overall genetic instrument for alcohol consumption 
with education in this MR study. However, the ADH1B 
gene variant was associated with education. The over-
all genetic instrument for alcohol consumption was 
associated with smoking initiation, and adjustment 
for genetic predisposition to smoking attenuated the 
estimates for alcohol consumption and most CVDs. If 
the association between genetically predicted alcohol 
consumption and smoking partly or entirely reflects 
vertical (mediated) pleiotropy rather than horizontal 
pleiotropy, adjustment for smoking may have attenu-
ated the full effect of alcohol consumption on risk of 
CVD. The smoking-adjusted estimates can be inter-
preted as the direct effect of alcohol consumption on 
CVD not mediated by smoking.
The validity of the results of an MR study depends 
on the assumptions that the instrumental variables 
are robustly associated with the risk factor and that 
pleiotropic or other direct causal pathways do not 
explain the association with the outcome (Figure 1). 
In the present study, we only used SNPs that were 
associated with alcohol consumption at a genome-
wide significance level.16 Furthermore, the associa-
tions of genetically predicted alcohol consumption 
with stroke and peripheral artery disease were similar 
in different MR analyses and remained after adjusting 
for smoking and in never smokers, suggesting that 
false positive findings due to horizontal pleiotropy via 
smoking are unlikely.
A limitation of this MR study is that despite large 
sample sizes, the precision was low in the analyses of 
outcomes with few cases. Another shortcoming is that 
UK Biobank participants were included in the dataset 
in which the genetic variants were derived and in both 
the exposure and outcome datasets for most analyses. 
This might have introduced bias in the causal estimates. 
However, genetic associations with outcomes in inde-
pendent datasets should not be affected by this sample 
overlap. Results for stroke and coronary artery disease 
were similar in analyses confined to data from the 
MEGASTROKE and CARDIoGRAMplusC4D consortia. 
Results were also similar using only the rs1229984 
variant, which was not discovered in UK Biobank. A fur-
ther limitation is that we cannot rule out that population 
stratification may have had some effect on the results. 
However, the vast majority of participants were of Euro-
pean ancestry, and the results were similar in analyses 
restricted to European-descent individuals. Finally, we 
could not investigate potential U-shaped or J-shaped 




 http://ahajournals.org by on June 18, 2020
Larsson et al Alcohol and Cardiovascular Disease
Circ Genom Precis Med. 2020;13:e002814. DOI: 10.1161/CIRCGEN.119.002814 June 2020 127
quantitative statements about the relative harm of mod-
erate drinking versus heavy drinking. However, as the 
prevalence of heavy drinking in the UK Biobank was low, 
it is unlikely that the burden of increased disease risk is 
restricted to heavy drinkers.
Conclusions
This study provides evidence of a causal relationship 
between higher alcohol consumption and increased 
risk of stroke and peripheral artery disease. The causal 
role of alcohol consumption for other CVDs requires 
further research.
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